IKZF1 and precursor B-cell acute lymphoblastic leukemia: Heterozygous IKZF1 N159Y occurs in less than 1% of B-ALL and has been reported to disrupt normal IKAROS function by affecting the DNA-binding domain of IKAROS [36,37].